Editor's Corner
Editorial
- Open AccessMaraviroc in PML-IRISA separate ball game under HIV infection and natalizumab?Israel Steiner, Felix Benninger
Articles
- Open AccessA comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patientsKaminie Moodley, Pierre L.A. Bill, Vinod Bhagu Patel
- Open AccessAquaporin-4 antibody titration in NMO patients treated with rituximabA retrospective studyPaola Valentino, Fabiana Marnetto, Letizia Granieri, Marco Capobianco, Antonio Bertolotto
- Open AccessAn observational study of alemtuzumab following fingolimod for multiple sclerosisMark Willis, Owen Pearson, Zsolt Illes, Tobias Sejbaek, Christian Nielsen, Martin Duddy, Kate Petheram, Caspar van Munster, Joep Killestein, Clas Malmeström, Emma Tallantyre, Neil Robertson
- Open AccessValidity of a PCR assay in CSF for the diagnosis of neurocysticercosisArturo Carpio, Alfredo Campoverde, Matthew L. Romo, Lorena García, Luis M. Piedra, Mónica Pacurucu, Nelson López, Jenner Aguilar, Sebastian López, Luis C. Vintimilla, Ana M. Toral, Pablo Peña-Tapia
- Open AccessMOG antibody–positive, benign, unilateral, cerebral cortical encephalitis with epilepsyRyo Ogawa, Ichiro Nakashima, Toshiyuki Takahashi, Kimihiko Kaneko, Tetsuya Akaishi, Yoshiki Takai, Douglas Kazutoshi Sato, Shuhei Nishiyama, Tatsuro Misu, Hiroshi Kuroda, Masashi Aoki, Kazuo Fujihara
- Open AccessMetabolomic signatures associated with disease severity in multiple sclerosisPablo Villoslada, Cristina Alonso, Ion Agirrezabal, Ekaterina Kotelnikova, Irati Zubizarreta, Irene Pulido-Valdeolivas, Albert Saiz, Manuel Comabella, Xavier Montalban, Luisa Villar, Jose Carlos Alvarez-Cermeño, Oscar Fernández, Roberto Alvarez-Lafuente, Rafael Arroyo, Azucena Castro
- Open AccessTime course of glatiramer acetate efficacy in patients with RRMS in the GALA studyMat D. Davis, Natalia Ashtamker, Joshua R. Steinerman, Volker Knappertz
Clinical/Scientific Notes
- Open AccessCharacteristics and pharmacodynamics of severe neuroinflammation in a child with neurolupusMichael R. Pranzatelli, Nathan R. McGee, Zeng Y. Wang, Brajesh K. Agrawal
- Open AccessEpstein-Barr–negative MS: a true phenomenon?Ruth Dobson, Jens Kuhle, Jaap Middeldorp, Gavin Giovannoni
- Open AccessDelayed tacrolimus leukoencephalopathy, a rare and reversible cause of dementiaDiego Barragán-Martínez, Ana Simarro-Díaz, Patricia Calleja-Castaño, Aurelio Hernández-Laín, Ana Ramos-González, Alberto Villarejo-Galende
- Open AccessParaneoplastic cerebellar degeneration associated with anti-ITPR1 antibodiesGiulia Berzero, Yael Hacohen, Lars Komorowski, Madeleine Scharf, Caroline Dehais, Delphine Leclercq, Virginie Fourchotte, Bruno Buecher, Jérôme Honnorat, Francesc Graus, Jean-Yves Delattre, Dimitri Psimaras
- Open AccessNegative commercial screening test for paraneoplastic antibodies in a case of opsoclonusNicolas Vandenbussche, Catherine Cassiman, Maarten Schrooten, Benjamin Gille, Xavier Bossuyt, Thierry Vincent, Philip Van Damme, Koen Poesen
- Open AccessSevere early natalizumab-associated PML in MS: Effective control of PML-IRIS with maravirocGabriel Bsteh, Michael Auer, Sarah Iglseder, Lisa-Maria Walchhofer, Dietmar Langenscheidt, Stefan Koppi, Gabriele Schauer-Maurer, Guenther Stockhammer, Thomas Berger
- Open AccessMaraviroc as possible treatment for PML-IRIS in natalizumab-treated patients with MSSibylle C. Hodecker, Klarissa H. Stürner, Veit Becker, Birte Elias-Hamp, Brigitte Holst, Manuel A. Friese, Christoph Heesen
- Open AccessRuxolitinib treatment in a patient with neuromyelitis optica: A case reportSibylle C. Hodecker, Jan-Patrick Stellmann, Sina C. Rosenkranz, Kim Young, Brigitte Holst, Manuel A. Friese, Christoph Heesen
Advertisement
Popular on
Neurology: Neuroimmunology & Neuroinflammation

Dr. Babak Hooshmand and Dr. David Smith
► Watch
Advertisement